Olaf Hardt R&D Reagents Miltenyi Biotec GmbH Biography Publications Institution JoVE Articles Olaf Hardt has not added a biography. If you are Olaf Hardt and would like to personalize this page please email our Author Liaison for assistance. Publications The Sialyl-glycolipid Stage-specific Embryonic Antigen 4 Marks a Subpopulation of Chemotherapy-resistant Breast Cancer Cells with Mesenchymal Features Breast Cancer Research : BCR. 2015 | Pubmed ID: 26607327 Transcriptional Pathways in CPGI2-Induced Adipocyte Progenitor Activation for Browning Frontiers in Endocrinology. 2015 | Pubmed ID: 26347713 Comparison Between Cold Plasma, Electrochemotherapy and Combined Therapy in a Melanoma Mouse Model Experimental Dermatology. Sep, 2013 | Pubmed ID: 23947672 Highly Sensitive Profiling of CD44+/CD24- Breast Cancer Stem Cells by Combining Global MRNA Amplification and Next Generation Sequencing: Evidence for a Hyperactive PI3K Pathway Cancer Letters. Dec, 2012 | Pubmed ID: 22771536 NeuroD1 Induce La Diferenciación Neuronal De Terminales En La Neurogénesis Olfatoria Proceedings of the National Academy of Sciences of the United States of America. Jan, 2010 | Pubmed ID: 20080708 Análisis De Expresión Génica Define Diferencias Entre Cada Región En Las Neuronas GABAérgicas Molecular and Cellular Neurosciences. Nov, 2008 | Pubmed ID: 18725299 Characterization of Peptides Released from Mitochondria: Evidence for Constant Proteolysis and Peptide Efflux The Journal of Biological Chemistry. Jan, 2005 | Pubmed ID: 15556950 El agotamiento de las células de ratón a partir de xenoinjertos de tumores humanos mejora significativamente análisis de aguas abajo de las células diana David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Medicine
El agotamiento de las células de ratón a partir de xenoinjertos de tumores humanos mejora significativamente análisis de aguas abajo de las células diana David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Medicine